Previously advertised studentships
The deadline for applications for these projects was 17 November 2019.
The ICR and Cancer Research UK Centre funded studentships
1) Structure and molecular function of the DREAM complex in gene expression programs of cellular quiescence.Dr Claudio Alfieri, Structural Biology, Molecular mechanisms for cell cycle regulation (Chelsea). View project proposal
2) Novel probes for investigating the tumour microenvironment and tissue targeting. Dr Gurdip Bhalay, Cancer Therapeutics Unit, Medicinal Chemistry Team 1 (Sutton). View project proposal
3) A fragment-based approach to identify protein-protein interaction inhibitors of Shelterin complex assembly. Professor Ian Collins, Cancer Therapeutics, Medicinal Chemistry 2 (Sutton). View project proposal
4) Defining replication mechanisms at the telomere end. Dr Max Douglas, Cancer Biology, Telomere Biology (Chelsea). View project proposal
5) Conformational switches of AXIN in Wnt/Beta-catenin signalling. Dr Sebastian Guettler, Structural Biology, Structural Biology of Cell Signalling (Chelsea). View project proposal
6) Enhancement of radiation induced cell death using ultrasound stimulated microbubbles. Dr Emma Harris. Radiotherapy and Imaging, Imaging for Radiotherapy Adaptation (Sutton). View project proposal
7) Integrative computational analysis of molecular and clinical data to dissect heterogeneity of therapy response in sarcomas.Dr Paul Huang. Molecular Pathology, Molecular and Systems Oncology (Chelsea). View project proposal
8) Evolutionary dynamics of MEK inhibitor sensitivity and resistance in diffuse midline glioma. Professor Chris Jones, Molecular Pathology, Glioma (Sutton). View project proposal
9) Understanding the homeostatic response to DNA repair inhibitors in breast cancer. Professor Chris Lord. Breast Cancer Research, Gene Function (Chelsea). View project proposal
10) Winners versus Losers: Harnessing Cell Competition to kill tumour cells. Professor Pascal Meier. Breast Cancer Research , Cell Death and Immunity (Chelsea). View project proposal
11) Systematic investigation of the mechanisms of replication fork protection, towards novel therapeutic strategy.Dr Wojciech Niedzwiedz.Cancer Biology, Genome Instability and Cancer (Chelsea). View project proposal
12) Advanced functional MRI for the characterisation of paediatric glioma and its response to therapy.Dr Simon Robinson,Radiotherapy and Imaging, Magnetic Resonance Imaging (Sutton). View project proposal
13) Functional characterisation of DNA damage response deficiency in cancer.Dr Anderson Wang. Cancer Therapeutics, Target biology and genomic instability (Sutton). View project proposal
14) Leveraging state-of-the-art methods in Artificial Intelligence and medical imaging for automated response evaluation and prediction of soft-tissue sarcomas to systemic treatment. Dr Matthew Blackledge.Radiotherapy and Imaging, Computational Imaging (Sutton). View project proposal
CRIS Cancer Foundation and ICR funded studentship
15) Characterisation and preclinical evaluation of a fibroblast-activating protein (FAP) targeted TRUCK CAR T-cell therapy for malignant pleural mesothelioma (MPM).Dr Astero Klampatsa. Cancer Therapeutics, Thoracic Oncology Immunotherapy Group (Sutton). View project proposal.
16) No longer available
Sarcoma UK and ICR funded studentship
17) TRANS-CASPS: Translational studies in the Cediranib in Alveolar Soft Part Sarcoma (CASPS) trial. Clinical Studies, Sarcoma Clinical Trials and Translational Research (Chelsea). View project proposal
NIHR Biomedical Research Centre funded studentships
These studentships fund clinically focused projects supporting the translational work of the NIHR Biomedical Research Centre at the Royal Marsden and The Institute of Cancer Research.
Each project has strong links to clinical units in the Royal Marsden NHS Foundation Trust building on strengths in basic sciences and their translational value. Students will have supervision from both a clinician and a basic scientist and be embedded in the research philosophy of the Biomedical Research Centre.
These studentships are open to all applicants (including overseas applicants). Please see our entry requirements for further eligibility information.
18) The development and implementation of Multi-Spectral CT imaging techniques and artificial intelligence methods within stereotactic radiosurgery treatment planning for oligometastases in the brain and intracranial meningiomas. Dr Dimitra Darambara. Radiotherapy and Imaging, Multimodality Molecular Imaging (Chelsea). View project proposal
19) Molecular mechanisms of acquired chemotherapy resistance in colorectal cancer and their implications for novel therapeutics development. Dr Marco Gerlinger.Molecular Pathology, Translational Oncogenomics.(Chelsea) View project proposal
20) Development and Implementation of Efficient Adaptive Designs in Early Phase Oncology Trials for Novel Agents. Professor Christina Yap. Clinical Studies, Clinical Trials and Statistics Unit and Drug Development Unit (Sutton). View project proposal
MRC funded industrial CASE (iCASE) programme in Enabling Integrated Drug Discovery
This programme offers an exciting opportunity to train as a researcher with exposure to and understanding of integrated interdisciplinary drug discovery in both academia and industry.
These studentships are funded by the Medical Research Council. Normally to be eligible for a full award a student must have no restrictions on how long they can stay in the UK and have been ordinarily resident in the UK for at least 3 years prior to the start of the studentship. Please see the MRC residency requirements for further information.
21) Investigating the druggability of the motif-mediated interactome with peptide PROTACs. Dr Norman Davey.Cancer Biology,Short Linear Motifs (Chelsea). View project proposal
22) In-silico approaches to enable optimisation of small molecule binding by perturbing and interacting with water networks. Dr Swen Hoelder. Cancer Therapeutics, Medicinal Chemistry team 4 (Sutton) View project proposal
23) Elucidating resistance to AKT inhibition in metastatic breast cancer.Professor Nicholas Turner. Breast Cancer Research,Molecular Oncology (Chelsea). View project proposal
24) Understanding the regulation and impact of variant splicing in non-small cell lung cancer.Professor Paul Workman, FRS, Dr Paul Clarke.Cancer Therapeutics, Signal Transduction and Molecular Pharmacology (Sutton) View project proposal